Apolipoprotein AV variants do not affect C-reactive protein levels in caucasian males

Physiological Research

Volumn 54, Issue 6, 2005, Pages 687-689

  Hubacek J A ^a,b,c   Skodova Z ^b   Lanska V ^a   Stavek P ^a   Adamkova V ^b   Poledne, R ^a,c  

^a Ctr for Exp Cardiovasc Research   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c Center for Cardiovascular Research   (Czech Republic)

Author keywords

Apolipoprotein AV; CRP; Genetics; Myocardial infarction; Polymorphism; Triglycerides

Indexed keywords

APOLIPOPROTEIN A5; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KOREA; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN VARIANT; RESTRICTION MAPPING;

ADULT; AGED; ALLELES; APOLIPOPROTEINS A; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 26844537877     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BLACK S, KUSHNER I, SAMOLS D: C-reactive protein. J Biol Chem 279: 48487-48490, 2004.
2. BAUM L, TOMLINSON B, THOMAS G: APOA5 -1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet 63: 377-379, 2003.
3. HUBÁČEK JA, ŠKODOVÁ Z, ADÁMKOVÁ V, LÁNSKÁ V, POLEDNE R: The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 65: 126-130, 2004a.
4. HUBÁČEK JA, ADÁMKOVÁ V, ČEŠKA R, POLEDNE R, HOŘÍNEK A, VRÁBLÍK M: New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res 53: 225-228, 2004b.
5. JANG Y, KIM JY, KIM OY, LEE JE, CHO H, ORDOVAS JM, LEE JH: The -1131T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr 80: 832-840, 2004.
6. KHOVIDHUNKIT W, DUCHATEAU PN, MEDZIHRADSZKY KF, MOSER AH, NAYA-VIGNE J, SHIGENAGA JK, KANE JP, GRUNFELD C, FEINGOLD KR: Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis 176: 37-44, 2004.
7. LAI CQ, TAI ES, TAN CE, CUTTER J, CHEW SK, ZHU YP, ADICONIS X, ORDOVAS JM: The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44: 2365-2373, 2003.
8. NABIKA T, NASREEN S, KOBAYASHI S, MASUDA J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 165: 201-204, 2002.
9. PENNACCHIO LA, OLIVIER M, HUBÁČEK JA, COHEN JC, FRUCHART JC, KRAUSS RM, RUBIN EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173, 2001.
10. PENNACCHIO LA, OLIVIER M, HUBÁČEK JA, KRAUSS RM, RUBIN EM, COHEN JC: Two independent apolipoprotein AV haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031-3038, 2002.
11. ŠEDA O, ŠEDOVÁ L: New apolipoprotein A-V: comparative genomics meets metabolism. Physiol Res 52: 141-146, 2003.
12. TALMUD PJ, HAWE E, MARTIN S, OLIVIER M, MILLER GJ, RUBIN EM, PENNACCHIO LA, HUMPHRIES SE: Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11: 3039-3046, 2002.
13. VAN DER VLIET HN, SAMMELS MG, LEEGWATER AC, LEVELS JH, REITSMA PH, BOERS W, CHAMULEAU RA: Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276: 44512-44520, 2001.